Predictive Oncology Inc.
POAI
$0.96
-$0.03-3.03%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.09% | 37.57% | -- | 18.91% | -23.29% |
| Total Depreciation and Amortization | 8.92% | 10.75% | -- | -8.83% | -35.90% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 844.23% | -106.38% | -- | -48.00% | -356.16% |
| Change in Net Operating Assets | 61.38% | -56.31% | -- | -427.84% | 365.86% |
| Cash from Operations | 77.86% | 30.30% | -- | 9.97% | 0.34% |
| Capital Expenditure | -- | -100.00% | -- | 97.45% | 87.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | 100.00% | -- | -- | -- |
| Cash from Investing | 20,933.33% | -100.00% | -- | 97.49% | 93.56% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -78.32% | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,323.93% | -75.92% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 167.06% | 26.43% | -- | 103.51% | -1.64% |